References
- Smuckler E. A. Alterations produced in the endoplasmic reticulum by carbon tetrachloride. Pan. Med. 1976; 18: 292
- Heimberg M., Weinstein I., Dishman G., Dunkerley A. The action of CCl4 on the transport and metabolism of triglycerides and fatty acids by the isolated perfused rat liver and its relationship to the etiology of fatty liver. J. Biol. Chem. 1962; 237: 3623
- Lombardi B. Pathogenesis of fatty liver. Fed. Proc. 1965; 24: 1200
- Kato R., Chiesara E., Vasanelli P. Factors influencing induction of hepatic microsomal drug metabolizing enzymes. Biochem. Pharmacol. 1962; 11: 210
- Dingell J. V., Heimberg M. The effects of aliphatic halogenated hydrocarbons on hepatic drug metabolism. Biochem. Pharmacol. 1968; 17: 1269
- Sasame H. A., Castro J. A., Gillette J. R. Studies on the destruction of liver microsomal cytochrome P‐450 by carbon tetrachloride administration. Biochem. Pharmacol. 1968; 17: 1759
- Fujimoto J. M., Plaa G. L. Effect of ethionine and CCl4 on urethane and phenobarbital induced changes in hexobarbital action. J. Pharmacol. Exp. Ther. 1961; 131: 282
- Garner R. C., McLean A. E. M. Increased susceptibility to carbon tetrachloride poisoning in the rat after pretreatment with oral phenobarbitone. Biochem. Pharmacol. 1969; 18: 645
- Stenger R. J., Miller R. A., Williamson J. N. Effects of phenobarbital pretreatment on the hepatotoxicity of carbon tetrachloride. Exp. Mol. Pathol. 1970; 13: 242
- Stenger R. J., Johnson E. A. Further observations upon the effects of phenobarbital pretreatment on the hepatotoxicity of carbon tetrachloride. Exp. Mol. Pathol. 1971; 14: 220
- Rao K. S., Glende E. A., Jr., Recknagel R. O. Effect of drug pretreatment on CCl4‐induced lipid peroxidation in rat liver microsomal lipids. Exp. Mol. Pathol. 1970; 12: 324
- Torrielli M. V., Gabriel L., Burdino E., Ugazio G. Osservazioni sperimentali sul meccanismo di azione di composti protectivi nei confronti dellepatossicita da alogenoalcani. 1975, Communicazione al 13° Congresso della Societa Italiana di Patologia Chianciano‐Siena, 12 giugno
- Burdino E., Danni O., Dianzani M. U., Milillo P. A., Poli G., Sena L. M., Torrielli M. V., Ugazio G. Halogenoalkane toxicity in different experimental conditions. Pan. Med. 1976; 18: 332
- Karmen A. A note on the spectrophotometric assay of glutamicoxalacetic transaminase in human blood serum. J. Clin. Invest. 1955; 34: 131
- Wroblewski F., LaDue J. S. Serum Glutamic‐pyruvic transaminase in cardiac and hepatic disease. Proc. Sco. Exp. Biol. Med. 1956; 91: 569
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265
- Ho I. K., Yamamoto I., Loh H. H. A model for the rapid development of dispositional and functional tolerance to barbiturates. Eur. J. Pharmacol. 1975; 30: 164
- Yamamoto I., Ho I. K., Loh H. H. Acceleration of pentobarbital metabolism in tolerant mice induced by pentobarbital pellet implantation. Life Sci. 1977; 20: 1353